Civic Intelligence

Pharmaceutical Human Resources Association

990EZ • Fiscal year 2022 • EIN 81-3060175

Jan 01, 2022 to Dec 31, 2022 • Filed on Apr 14, 2023

2000 Galloping Rd Ste K1-1106Kenilworth, NJ 07033

(000) 000-0000

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

54th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2022 filings • NTEE S41 • <$500k nonprofits • Source year 2022

Liabilities / Revenue

53rd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2022 filings • NTEE S41 • <$500k nonprofits • Source year 2022

Net Margin

32nd percentile

-6.0%

Higher net margin than 32% of similar nonprofits.

2022 filings • NTEE S41 • <$500k nonprofits • Source year 2022

Top Officer Pay

80th percentile

$0

Higher top officer pay than 80% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2022 filings • NTEE S41 • <$500k nonprofits • Source year 2022

Asset Growth

32nd percentile

-8.9%

Faster asset growth than 32% of similar nonprofits.

2022 filings • NTEE S41 • <$500k nonprofits • Annualized from 2021 to 2022

Revenue Growth

41st percentile

5.5%

Faster revenue growth than 41% of similar nonprofits.

2022 filings • NTEE S41 • <$500k nonprofits • Annualized from 2021 to 2022

Assets

Down

$54,112

Down $5,275 (-8.9%) from 2021

Net Assets

Down

$54,112

Down $5,275 (-8.9%) from 2021

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

Up

$87,980

Up $4,604 (+5.5%) from 2021

Expenses

Up

$93,255

Up $25,153 (+37%) from 2021

Net Income

Down

-$5,275

Down $20,549 (-135%) from 2021

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$60K$40K$20K$0Assets 2021: $59,387Net Assets 2021: $59,3872021Assets 2022: $54,112Liabilities 2022: $0Net Assets 2022: $54,1122022Assets 2023: $25,672Net Assets 2023: $25,6722023Assets 2024: $44,132Net Assets 2024: $44,1322024

Highlighted filing

2022

Assets$54,112
Liabilities$0
Net Assets$54,112

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$150K$100K$50K$0-$50KRevenue 2021: $83,376Expenses 2021: $68,102Net Income 2021: $15,2742021Revenue 2022: $87,980Expenses 2022: $93,255Net Income 2022: -$5,2752022Revenue 2023: $98,346Expenses 2023: $126,786Net Income 2023: -$28,4402023Revenue 2024: $120,000Expenses 2024: $101,540Net Income 2024: $18,4602024

Highlighted filing

2022

Revenue$87,980
Expenses$93,255
Net Income-$5,275
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Apr 14, 2023
Return Version
2022v5.0
Gross Receipts
$87,980
Mission and Program Overview

Mission

See Schedule O

Program Services

DescriptionGrantsExpenses
0--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Tanesha DuncanChair - 1122-123122-$0--
Roelof KistemakerCo-Chair - 1122-123122-$0--
Jeffrey GellerTreasurer - 7118-Present-$0--
Filing and Contact Details

Filer

Filer Name
Pharmaceutical Human Resources Association
EIN
81-3060175
Phone
0000000000
Address
2000 GALLOPING RD STE K1-1106, KENILWORTH, NJ 07033

Signing Officer

Name
Jeffrey Geller
Title
Treasurer PHRA
Phone
9082303874
Signed
2023-04-14
Supplemental Narrative

Additional Explanations

Schedule O:

Form and Line Reference: Part I, Line 16: Wire Fees $45 PHRA Dinner $724.89 E-file fee for 2021 $100.85 Penalty for late submission and not filing electronically (IRS has agreed per letter dated 4/3/23 will refund in 6-8 weeks) $2,340 Form and Line Reference: Part III, Line Primary Purpose: The Pharmaceutical Human Resources Association (PHRA) is a professional association of companies represented by compensation and benefits human resources executives that exists to improve and serve the compensation and benefits human resources professionals in the pharmaceutical and biopharmaceutical industries. Form and Line Reference; Part III, Line 28 The PHRA has held its annual meeting for the association and meets for its sub-committees to discuss trends and best practices relating to compensation and benefits in the pharmaceutical and biopharmaceutical industries. These meetings include presentations by outside groups and internal discussions. Form and Line Reference: Part III, Line 29 The PHRA has also conducted ad hoc surveys and individual companies have responded to PHRA sponsored annual studies to educate the association's members on trends and best practices in the pharmaceutical and biopharmaceutical industries.

Raw XML Appendix129 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BenefitsPaidToOrForMembersAmt00
IRS990EZ/BooksInCareOfDetail/PersonNm0Jeffrey Geller
IRS990EZ/BooksInCareOfDetail/PhoneNum09082303874
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt02000 Galloping Hill Road K1-1106
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Kenilworth
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NJ
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd007033
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt059387
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt054112
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/CntrctRcvdGreaterThan100KCnt00
IRS990EZ/ContributionsGiftsGrantsEtcAmt00
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-5275
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt090044
IRS990EZ/FiledScheduleAInd0false
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt059387
IRS990EZ/Form990TotalAssetsGrp/EOYAmt054112
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GainOrLossFromSaleOfAssetsAmt00
IRS990EZ/GamingGrossIncomeAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt00
IRS990EZ/GrossProfitLossSlsOfInvntryAmt00
IRS990EZ/GrossReceiptsAmt087980
IRS990EZ/GrossReceiptsForPublicUseAmt00
IRS990EZ/GrossSalesOfInventoryAmt00
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InitialReturnInd0X
IRS990EZ/InitiationFeesAndCapContriAmt00
IRS990EZ/InvestmentIncomeAmt00
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LandAndBuildingsGrp/EOYAmt00
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MembershipDuesAmt087980
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt059387
IRS990EZ/NetAssetsOrFundBalancesEOYAmt054112
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt059387
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt054112
IRS990EZ/OccupancyRentUtltsAndMaintAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Tanesha Duncan
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Roelof Kistemaker
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Jeffrey Geller
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Chair - 1122-123122
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Co-Chair - 1122-123122
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Treasurer - 7118-Present
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501cInd0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt00
IRS990EZ/OtherAssetsTotalDetail/EOYAmt00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherEmployeePaidOver100kCnt00
IRS990EZ/OtherExpensesTotalAmt03211
IRS990EZ/OtherRevenueTotalAmt00
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0See Schedule O
IRS990EZ/PrintingPublicationsPostageAmt00
IRS990EZ/ProgramServiceRevenueAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt00
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt00
IRS990EZ/SaleOfAssetsGrossAmt00
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SpecialEventsNetIncomeLossAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NJ
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt093255
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt087980
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TypeOfOrganizationAssocInd0X
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Form and Line Reference: Part I, Line 16: Wire Fees $45 PHRA Dinner $724.89 E-file fee for 2021 $100.85 Penalty for late submission and not filing electronically (IRS has agreed per letter dated 4/3/23 will refund in 6-8 weeks) $2,340 Form and Line Reference: Part III, Line Primary Purpose: The Pharmaceutical Human Resources Association (PHRA) is a professional association of companies represented by compensation and benefits human resources executives that exists to improve and serve the compensation and benefits human resources professionals in the pharmaceutical and biopharmaceutical industries. Form and Line Reference; Part III, Line 28 The PHRA has held its annual meeting for the association and meets for its sub-committees to discuss trends and best practices relating to compensation and benefits in the pharmaceutical and biopharmaceutical industries. These meetings include presentations by outside groups and internal discussions. Form and Line Reference: Part III, Line 29 The PHRA has also conducted ad hoc surveys and individual companies have responded to PHRA sponsored annual studies to educate the association's members on trends and best practices in the pharmaceutical and biopharmaceutical industries.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Schedule O:
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Jeffrey Geller
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Treasurer PHRA
ReturnHeader/BusinessOfficerGrp/PhoneNum09082303874
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-04-14
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PHARMACEUTICAL HUMAN RESOURCES ASSOCIATION
ReturnHeader/Filer/BusinessNameControlTxt0PHAR
ReturnHeader/Filer/EIN0813060175
ReturnHeader/Filer/PhoneNum00000000000
ReturnHeader/Filer/USAddress/AddressLine1Txt02000 GALLOPING RD STE K1-1106
ReturnHeader/Filer/USAddress/CityNm0KENILWORTH
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NJ
ReturnHeader/Filer/USAddress/ZIPCd007033
ReturnHeader/ReturnTs02023-04-14T19:30:04Z
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0Jeffrey
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0Geller
ReturnHeader/TaxPeriodBeginDt02022-01-01
ReturnHeader/TaxPeriodEndDt02022-12-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings